3B Blackbio Dx Board of Directors

Get the latest insights into the leadership at 3B Blackbio Dx. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dhirendra DubeyChairman & Managing Director
N K DubeyWhole Time Director
Mithala DubeyNon Executive Director
Abdul Moin KhanNon Executive Independent Director
Harihar Prasad ThapakNon Executive Independent Director
Navneet KaurCompany Secretary & Compliance Officer
Vivek SaihgalNon Executive Independent Director

3B Blackbio Dx Share price

3BBLACKBIO

1355.15

32.90 (-2.37%)
NSE
BSE
Last updated on 22 Apr, 2026 | 15:44 IST
Today's High

1399.00

Today's Low

1341.05

52 Week Low

1281.10

52 Week High

1410.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

3B Blackbio Dx FAQs

The board at 3B Blackbio Dx consists of experienced professionals, including Dhirendra Dubey, N K Dubey, and others, overseeing the company’s strategic and corporate governance.

Directors at 3B Blackbio Dx are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dhirendra Dubey is the current chairman at 3B Blackbio Dx.

Executive directors at 3B Blackbio Dx are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, 3B Blackbio Dx adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At 3B Blackbio Dx, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost